St. Elizabeth Healthcare’s Post

Summary of my presentation, Radiation Is ‘Practice-Changing’ for Some Lung Cancer Subsets - Percy Lee, MD, FASTRO MJH Life Sciences® EGFR Resisters ALK Positive Inc. #Cancer #LCSM #OncoDaily #Oncology #PatientCare

It’s true. According to #LUNGevity, it’s estimated that nearly 65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers. Learn more about GW Cancer Center’s Thoracic Oncology Program. https://bit.ly/46RfOLQ #LivingWithLungCancer #LCAM #lungcancer #GWCancerCenter

It’s true. According to #LUNGevity, it’s estimated that nearly 65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers. Learn more about GW Cancer Center’s Thoracic Oncology Program. https://bit.ly/46RfOLQ #LivingWithLungCancer #LCAM #lungcancer #GWCancerCenter

Exciting news for the prostate cancer community! The American Urological Association, American Society for Radiation Oncology, and Society of Urologic Oncology have released a new guideline on salvage therapy for prostate cancer. This evidence-based guideline offers essential recommendations for clinicians dealing with recurrence after initial treatment, covering key aspects like treatment decision-making and delivery. Find out more about the important insights provided in this guideline by accessing the full article now at buff.ly/4afcLOL. #Prostate

#headandneckcancer Very useful in public sector: radiotherapy using VMAT with 6 MV photons. One QUAD shot cycle included 14.8 Gy in 4 fractions with at least 6-hour intervals over 2 consecutive days, repeated every 3–6 weeks up to 3 cycles.

Did you know that myeloma is the second most prevalent type of blood cancer, making up around 1% of all cancer cases? Explore the Myeloma section on our website and download the Myeloma Patient Guide in PDF version: https://lnkd.in/eQT4R2Xm

Dear Colleagues, At our upcoming AON Regional Clinical Summit 2024, the first of its kind in Indianapolis, we have a grand educational program, titled ‘Expert Insights and System-Based Care Trends in Early-Stage NSCLC and Melanoma, Metastatic Bladder Cancer, and Relapsed/Refractory Follicular Lymphoma'. These four malignancies has few significant advances in treatment options and management. This program will focus on identification of these patients, utilization of different targets, and their toxicity and efficacy profiles. The other goal of this program is to identify and overcome system-, team-, and individual-level barriers that contribute to cancer screening and care of this patient population. We conducted a baseline survey to understand the perceptions of healthcare providers involved in the care of these patients. Now, we invite you to join a 4-hour audit-feedback program led by expert speakers, Ralph Boccia MD, FACP, Brian Mulherin MD, Taral Patel MD, Joseph Murray MD, PhD, Ying-Chun Lo MD, PhD, Jason Luke MD, FACP, Bradley Mcgregor MD, Sameh Gaballa MD and Jeanna Knoble MD with I, M. Sarfraz Nawaz and Ryan Atkinson Pharm.D., MBA serving as Moderators. The program will help to understand the role, efficacy, side effects monitoring and management along with addressing the barriers involved in the care of this complex patient population. Please save the date for this Live / virtual learning session on Saturday, APR 20, 2024, at 8:00 AM EST. CME/CE credits provided. You can attend in-person at JW Marriott Indianapolis or virtually. Further details about joining the session virtually are as below: 10 mins before the session, click here. https://lnkd.in/gbRDib-j or copy and paste this URL into your internet browser, preferably Google Chrome. 2. Complete the pre-survey 3. Click the "Launch Meeting" button to access the session 4. Follow the on-screen instructions to join the meeting 5. Complete the post-survey by clicking the "Continue" button and submit I am very confident that this opportunity will improve our understanding of this patient population and our roles in their care. Please try your best to attend the event. Looking forward to joining you all for this learning session. Best Regards, M Sarfraz Nawaz American Oncology Network PRIME Education Hematology Oncology Of Indiana #AON #HOI #CommunityOncology #OncologyEducation

#ICYMI: BrYet CEO Dr. Mauro Ferrari recently joined leading cancer researchers to discuss the future of cancer care during the "Precision Oncology: Tailored Care for Better Outcome" panel at the 2024 Nixon National Cancer Conference. Watch the panel here to learn how we can transform treatment strategies and custom-tailor #cancer care for each patient: https://lnkd.in/e-sQrSRR

Radiation has now been shown in 3 separate trials to improve survival in metastatic cancer patients. Great news as we push for better!! Link: https://lnkd.in/gj75g6HF If you or a family member has metastatic cancer, it is probably wise to make sure a #radonc #radiationoncology physician is on your care team. The amount of information out there today is staggering and it takes a team. This weeks article reviews 4 trials - just from this year showing radiation offers significant improvements in outcomes.

Discover how vMTBs are shaping the future of cancer care - Prof. Dr. Mutlu Demiray The Oncologist Journal Medicana Health Group #Cancer #CancerCaseStudies #OncoDaily #Oncology #PrecisionOncology #TheOncologist